Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

Abstract Gastrointestinal (GI) malignant neoplasms have a high global incidence and treatment prospects for patients with advanced GI tumors are dismal. PD-1/PD-L1 inhibitors emerged as a frontline treatment for several types of cancer. However, the shortcomings of PD-1/PD-L1 inhibitors have been ob...

Descrición completa

Detalles Bibliográficos

Principais autores:	Dongxu Wang, Jianzhen Lin, Xu Yang, Junyu Long, Yi Bai, Xiaobo Yang, Yilei Mao, Xinting Sang, Samuel Seery, Haitao Zhao
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2019-04-01
Series:	Journal of Hematology & Oncology
Assuntos:	Gastrointestinal malignancies PD-1/PD-L1 blockade Immune checkpoint inhibitor Combination immunotherapy Clinical application Rationale
Acceso en liña:	http://link.springer.com/article/10.1186/s13045-019-0730-9
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!